ÍøºìºÚÁÏ

Skip to main content
(352) 265-0820

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh
(352) 265-0820 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

379 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2020

Atrioventricular Nodal Reentrant Tachycardia in Very Elderly Patients: A Single-center Experience.

The Journal of innovations in cardiac rhythm management

•

2020

Bupropion in the treatment of postural orthostatic tachycardia syndrome (POTS): a single-center experience.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

•

2020

Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

Data in Brief

2020

Long-term mortality after massive, submassive, and low-risk pulmonary embolism.

Vascular medicine (London, England)

•

2020

Polypill for prevention of cardiovascular diseases.

Lancet (London, England)

•